1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
Clinical trial NCT02000596 · TERMINATED
Trial details
- NCT number
- NCT02000596
- Sponsor
- University of Maryland, Baltimore
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-11-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.